Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) drugs and antidiabetic medications. Its structural configuration supports the formation of bioactive molecules with high enantioselectivity, making it valuable in asymmetric synthesis. Commonly employed in the preparation of protease inhibitors and kinase inhibitors due to its ability to enhance metabolic stability and binding affinity. Also utilized in medicinal chemistry for constructing peptidomimetic frameworks, where the (R)-configuration contributes to improved pharmacokinetic properties.